Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1961 1
1965 3
1968 1
1971 1
1973 1
1974 4
1975 7
1976 6
1977 6
1978 5
1979 4
1980 14
1981 5
1982 3
1983 4
1984 5
1985 8
1986 12
1987 8
1988 4
1989 9
1990 6
1991 10
1992 7
1993 6
1994 9
1995 10
1996 16
1997 12
1998 18
1999 16
2000 16
2001 17
2002 12
2003 8
2004 14
2005 8
2006 13
2007 18
2008 10
2009 10
2010 15
2011 12
2012 13
2013 12
2014 12
2015 8
2016 16
2017 15
2018 14
2019 20
2020 10
2021 14
2022 11
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Guide and Update on Porphyrias.
Stölzel U, Doss MO, Schuppan D. Stölzel U, et al. Gastroenterology. 2019 Aug;157(2):365-381.e4. doi: 10.1053/j.gastro.2019.04.050. Epub 2019 May 11. Gastroenterology. 2019. PMID: 31085196 Review.
Management of attacks requires intensive care, strict avoidance of porphyrinogenic drugs and other precipitating factors, caloric support, and often heme therapy. The non-acute porphyrias are porphyria cutanea tarda, erythropoietic protoporphyria, X-linked pr …
Management of attacks requires intensive care, strict avoidance of porphyrinogenic drugs and other precipitating factors, caloric support, a …
Epidermolysis bullosa acquisita.
Miyamoto D, Gordilho JO, Santi CG, Porro AM. Miyamoto D, et al. An Bras Dermatol. 2022 Jul-Aug;97(4):409-423. doi: 10.1016/j.abd.2021.09.010. Epub 2022 Jun 11. An Bras Dermatol. 2022. PMID: 35701269 Free PMC article.
Due to the similarity of the clinical findings of epidermolysis bullosa acquisita with other diseases of the pemphigoid group and with porphyria cutanea tarda, the diagnosis is currently confirmed mainly based on the clinical correlation with histopathologica …
Due to the similarity of the clinical findings of epidermolysis bullosa acquisita with other diseases of the pemphigoid group and with po …
Porphyria.
Bissell DM, Anderson KE, Bonkovsky HL. Bissell DM, et al. N Engl J Med. 2017 Aug 31;377(9):862-872. doi: 10.1056/NEJMra1608634. N Engl J Med. 2017. PMID: 28854095 Review. No abstract available.
The Porphyrias.
Muschalek W, Hermasch MA, Poblete-Gutiérrez P, Frank J. Muschalek W, et al. J Dtsch Dermatol Ges. 2022 Mar;20(3):316-331. doi: 10.1111/ddg.14743. J Dtsch Dermatol Ges. 2022. PMID: 35304965 Review.
Here, we provide an overview of the etiopathogenesis, clinic, differential diagnosis, laboratory diagnostics and therapy of these complex metabolic disorders and cover in detail the most common form of porphyria worldwide (porphyria cutanea tarda), the most f …
Here, we provide an overview of the etiopathogenesis, clinic, differential diagnosis, laboratory diagnostics and therapy of these complex me …
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Ferreli C, et al. Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4. Clin Rev Allergy Immunol. 2017. PMID: 28712039 Review.
This article reviews the clinical presentation with emphasis on cutaneous disease, etiopathogenesis, diagnosis, and treatment options available for the different forms of scleroderma firstly and for scleroderma-like disorders, including scleromyxedema, scleredema, nephrogenic sys …
This article reviews the clinical presentation with emphasis on cutaneous disease, etiopathogenesis, diagnosis, and treatment options availa …
Update on the Porphyrias.
Dickey AK, Leaf RK, Balwani M. Dickey AK, et al. Annu Rev Med. 2024 Jan 29;75:321-335. doi: 10.1146/annurev-med-042921-123602. Epub 2023 Aug 4. Annu Rev Med. 2024. PMID: 37540847 Free article. Review.
Porphyria Cutanea Tarda.
Janssens L, Ji H, Greenlund A. Janssens L, et al. Clin Gastroenterol Hepatol. 2021 Sep;19(9):A19. doi: 10.1016/j.cgh.2020.05.028. Epub 2020 May 21. Clin Gastroenterol Hepatol. 2021. PMID: 32447017 No abstract available.
Porphyria Cutanea Tarda.
Jin MF, Wieland CN. Jin MF, et al. Mayo Clin Proc. 2021 May;96(5):1248-1249. doi: 10.1016/j.mayocp.2020.12.025. Mayo Clin Proc. 2021. PMID: 33958055 No abstract available.
The cutaneous porphyrias.
Schulenburg-Brand D, Katugampola R, Anstey AV, Badminton MN. Schulenburg-Brand D, et al. Dermatol Clin. 2014 Jul;32(3):369-84, ix. doi: 10.1016/j.det.2014.03.001. Epub 2014 May 5. Dermatol Clin. 2014. PMID: 24891059 Review.
497 results